Busque entre los 167610 recursos disponibles en el repositorio
Mostrar el registro sencillo del ítem
dc.date.accessioned | 2019-11-06T16:36:01Z | |
dc.date.available | 2019-11-06T16:36:01Z | |
dc.date.issued | 2014 | |
dc.identifier.uri | http://sedici.unlp.edu.ar/handle/10915/85070 | |
dc.description.abstract | Phospholamban (PLN) is a phosphoprotein in cardiac sarcoplasmic reticulum (SR) that is a reversible regulator of the Ca2+-ATPase (SERCA2a) activity and cardiac contractility. Dephosphorylated PLN inhibits SERCA2a and PLN phosphorylation, at either Ser16 by PKA or Thr17 by Ca2+-calmodulin-dependent protein kinase (CaMKII), reverses this inhibition. Through this mechanism, PLN is a key modulator of SR Ca2+ uptake, Ca2+ load, contractility, and relaxation. PLN phosphorylation is also the main determinant of ß1-adrenergic responses in the heart. Although phosphorylation of Thr17 by CaMKII contributes to this effect, its role is subordinate to the PKA-dependent increase in cytosolic Ca2+, necessary to activate CaMKII. Furthermore, the effects of PLN and its phosphorylation on cardiac function are subject to additional regulation by its interacting partners, the anti-apoptotic HAX-1 protein and Gm or the anchoring unit of protein phosphatase 1. Regulation of PLN activity by this multimeric complex becomes even more important in pathological conditions, characterized by aberrant Ca2+-cycling. In this scenario, CaMKII-dependent PLN phosphorylation has been associated with protective effects in both acidosis and ischemia/reperfusion. However, the beneficial effects of increasing SR Ca2+ uptake through PLN phosphorylation may be lost or even become deleterious, when these occur in association with alterations in SR Ca2+ leak. Moreover, a major characteristic in human and experimental heart failure (HF) is depressed SR Ca2+ uptake, associated with decreased SERCA2a levels and dephosphorylation of PLN, leading to decreased SR Ca2+ load and impaired contractility. Thus, the strategy of altering SERCA2a and/or PLN levels or activity to restore perturbed SR Ca2+ uptake is a potential therapeutic tool for HF treatment. We will review here the role of CaMKII-dependent phosphorylation of PLN at Thr17 on cardiac function under physiological and pathological conditions. | en |
dc.language | en | es |
dc.subject | Acidosis | es |
dc.subject | CaMKII | es |
dc.subject | Heart failure | es |
dc.subject | Ischemia/reperfusion injury | es |
dc.subject | Myocardium | es |
dc.subject | PLN regulation | es |
dc.title | The role of CaMKII regulation of phospholamban activity in heart disease | en |
dc.type | Articulo | es |
sedici.identifier.other | doi:10.3389/fphar.2014.00005 | es |
sedici.identifier.other | eid:2-s2.0-84893511592 | es |
sedici.identifier.issn | 1663-9812 | es |
sedici.creator.person | Mattiazzi, Alicia Ramona | es |
sedici.creator.person | Kranias, Evangelina G. | es |
sedici.subject.materias | Ciencias Médicas | es |
sedici.description.fulltext | true | es |
mods.originInfo.place | Facultad de Ciencias Médicas | es |
mods.originInfo.place | Centro de Investigaciones Cardiovasculares | es |
sedici.subtype | Revision | es |
sedici.rights.license | Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) | |
sedici.rights.uri | http://creativecommons.org/licenses/by-nc-sa/4.0/ | |
sedici.description.peerReview | peer-review | es |
sedici.relation.journalTitle | Frontiers in Pharmacology | es |
sedici.relation.journalVolumeAndIssue | vol. 5 | es |
sedici.rights.sherpa | * Color: green * Pre-print del autor: si * Post-print del autor: si * Versión de editor/PDF:si * Condiciones: >>On open access repositories >>Authors retain copyright >>Creative Commons Attribution License >>Published source must be acknowledged with citation >>First publication by Frontiers Media must be acknowledged >>Publisher's version/PDF may be used >>Articles are placed in PubMed Central immediately on behalf of authors. >>All titles are open access journals >>Publisher last reviewed on 24/07/2019 * Link a Sherpa: http://sherpa.ac.uk/romeo/issn/1663-9812/es/ |